Funding-DEPARTMENT OF DEFENSE PEER REVIEWED MEDICAL RESEARCH PROGRAM FUNDING OPPORTUNITIES FOR FISCAL YEAR 2012; May 9, 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $50 million (M) to the Department of Defense Peer Reviewed Medical Research Program (PRMRP). The vision of the PRMRP is to improve the health and well-being of all military service members, veterans, and beneficiaries. The PRMRP challenges the scientific and clinical communities to address one of the FY12 congressionally directed topic areas with original ideas that foster new directions in basic science and translational research; novel product development leading to improved therapeutic or diagnostic tools; or clinical trials that address an immediate clinical need. This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

Congressionally Directed Topic Areas: The FY12 PRMRP will solicit research applications for the following 22 topics areas: Arthritis, Composite Tissue Transplantation, Dystonia, Drug Abuse, Epilepsy, Food Allergies, Fragile X Syndrome, Hereditary Angioedema, Inflammatory Bowel Disease, Interstitial Cystitis, Listeria Vaccine for Infectious Diseases, Lupus, Malaria, Nanomedicine for Drug Delivery Science, Neuroblastoma, Osteoporosis and Related Bone Disease, Paget's Disease, Polycystic Kidney Disease, Post-Traumatic Osteoarthritis, Scleroderma, Tinnitus, and Tuberculosis.

Military Relevance: Relevance to the health care needs of the military service members, veterans, and beneficiaries is a key feature of each FY12 PRMRP award mechanism.

This information can be found at the following link: http://cdmrp.army.mil/funding/prmrp.shtml.

The Program Announcement summaries are listed below:

PRMRP:  (4 Program Announcements)

Clinical Trial Awards

Assistant Professor level or above (or equivalent) are eligible to apply.

Pre-application (Letter of Intent) is required and due June 6, 2012, 5:00 p.m. Eastern time.

Supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in the topic of interest.

Clinical Trial is expected to be initiated within 12 months of award date. 

Maximum funding of $2.2M for direct costs (plus indirect costs).

Maximum period of performance is 5 years.

Discovery Awards

All investigators are eligible.

Pre-application (Letter of Intent) is required and due May 9, 2012, 5:00 p.m. Eastern time.

Supports the exploration of a highly  innovative new concept or untested theory in the topic area of interest.  

Inclusion of preliminary data is strongly discouraged

Clinical trials will not be funded.

Maximum funding of $125,000 for direct costs (plus indirect costs).

Maximum period of performance is 18 months.

Investigator-Initiated Research Awards

Assistant Professor level or above (or equivalent) are eligible to apply.

Partnering Principal Investigator option available.

Pre-application (pre-proposal) is required and due April 10, 2012, 5:00 p.m. Eastern time..

Supports research that will make an original and important contribution to the field of research or patient care in the topic area of interest.

Clinical trials are not allowed.

Maximum funding of $750,000 for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

Technology/Therapeutic Development Awards

Assistant Professor level or above (or equivalent) are eligible to apply.

Pre-application (Letter of Intent) is required and due June 6, 2012, 5:00 p.m. Eastern time..

Supports the development of new diagnostics or therapies that have the potential to make a strong clinical impact in the topic area of interest.

Product-oriented:  Device, Drug, Clinical guidance/guidelines.

Clinical trials are not allowed.

Maximum funding of $1.5M for direct costs (plus indirect costs).

Maximum period of performance is 3 years

All applications must conform to the program announcement and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application (a pre-proposal or Letter of Intent as designated) is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the PRMRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or 301-682-5507.